Suppr超能文献

系统评价和网络荟萃分析评估经蝶窦手术治疗垂体瘤的疗效和安全性比较。

Systematic review and network meta-analysis assess the comparative efficacy and safety of transsphenoidal surgery for pituitary tumor.

机构信息

Department of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, 210000, China.

出版信息

Neurosurg Rev. 2021 Feb;44(1):515-527. doi: 10.1007/s10143-020-01240-3. Epub 2020 Feb 8.

Abstract

To quantitatively synthesize the comparative efficacy and safety of the most common surgical approaches including endonasal transsphenoidal endoscopic surgery (ETES), sublabial transsphenoidal microsurgery (STMS) and endonasal transsphenoidal microsurgery (ETMS) for all kinds of pituitary tumors. This systematic review and network meta-analysis was performed on randomized controlled trials (RCTs) and comparison studies from databases of Pubmed, EMBASE, and the Cochrane library. We selected the rate of gross complete resection as our primary outcome of efficacy. And the incidence of all complications, cerebrospinal fluid (CSF) leak, diabetes insipidus, nasal septal perforation, death, and bleeding were designed as our primary outcomes of safety. Twenty-seven studies with 2618 patients were included in this network meta-analysis. On efficacy, there was no statistical difference among the three methods including ETES, STMS, and ETMS. As for safety, results indicated that the incidence of total complications of STMS (OR = 4.74; 95% CI 1.03, 40.14) is significantly superior to ETES. And the incidence of diabetes insipidus of ETMS (OR = 2.21; 95% CI 1.31, 3.81) was significantly superior to that of ETES. Besides, there was no statistical difference in the other complications including CSF leak, nasal septal perforation, death, and bleeding. We clarified the overpraise of the efficacy of endoscopy especially the endonasal transsphenoidal approach, and verified that all the approaches owned similar efficacy. Moreover, we recommended the endoscopy to be the first choice for pituitary tumors, because it demonstrated the best safety.

摘要

目的

系统评价和网络荟萃分析经鼻蝶内镜手术(ETES)、经唇下蝶窦显微手术(STMS)和经鼻蝶窦显微手术(ETMS)治疗各种垂体瘤的疗效和安全性。

方法

我们在 Pubmed、EMBASE 和 Cochrane 图书馆的数据库中对随机对照试验(RCT)和对照研究进行了系统评价和网络荟萃分析。我们选择大体全切除率作为疗效的主要结局,所有并发症的发生率、脑脊液(CSF)漏、尿崩症、鼻中隔穿孔、死亡和出血作为安全性的主要结局。

结果

本网络荟萃分析共纳入 27 项研究,共计 2618 例患者。在疗效方面,ETES、STMS 和 ETMS 三种方法之间无统计学差异。在安全性方面,结果表明 STMS 的总并发症发生率(OR = 4.74;95% CI 1.03, 40.14)显著优于 ETES。而 ETMS 的尿崩症发生率(OR = 2.21;95% CI 1.31, 3.81)显著优于 ETES。此外,CSF 漏、鼻中隔穿孔、死亡和出血等其他并发症的发生率在三种方法之间无统计学差异。

结论

本研究澄清了内镜治疗特别是经鼻蝶入路疗效的过度评价,证实了所有方法均具有相似的疗效。此外,我们推荐内镜治疗作为垂体瘤的首选方法,因为它具有最佳的安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验